NVCT NASDAQ
Nuvectis Pharma, Inc.
1W: -1.6%
1M: +22.8%
3M: +128.3%
YTD: +181.9%
1Y: +282.0%
3Y: +69.8%
$23.99
+1.50 (+6.67%)
Weekly Expected Move ±10.7%
$19
$21
$24
$27
$29
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$1.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$636.6M
52W Range5.55-29.275
Volume221,080
Avg Volume268,238
Beta-0.26
Dividend—
Analyst Ratings
Company Info
CEORon Bentsur
Employees16
SectorHealthcare
IndustryBiotechnology
IPO Date2022-02-04
Websitenuvectis.com
1 Bridge Plaza
Fort Lee, NJ 07024
US
Fort Lee, NJ 07024
US
201 614 3150
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.
Latest News
Bank of New York Mellon Corp Buys Shares of 36,770 Nuvectis Pharma, Inc. $NVCT
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Receives $36.25 Consensus Target Price from Analysts
BlackRock Inc. Acquires New Stake in Nuvectis Pharma, Inc. $NVCT
Nuvectis Pharma To Participate in Upcoming Investor Conferences
Nuvectis Stock Surges Around 97% in 3 Months: Here's Why
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Carson Michael J. | A-Award | 30,000 | — | 2026-08-03 |
| BENTSUR RON | P-Purchase | 12,500 | $20.00 | 2026-06-30 |
| Mosseri Marlio Charl | P-Purchase | 50,000 | $18.32 | 2026-06-30 |
| Hoberman Kenneth | A-Award | 35,000 | — | 2026-06-11 |
| Oliviero James F III | A-Award | 35,000 | — | 2026-06-11 |